Literature DB >> 21963833

Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.

David Zisa1, Arsalan Shabbir, Michalis Mastri, Tyler Taylor, Ilija Aleksic, Mary McDaniel, Gen Suzuki, Techung Lee.   

Abstract

The skeletal muscle is endowed with an impressive ability to regenerate after injury, and this ability is coupled to paracrine production of many trophic factors possessing cardiovascular benefits. Taking advantage of this humoral capacity of the muscle, we recently demonstrated an extracardiac therapeutic regimen based on intramuscular delivery of VEGF-A(165) for repair of the failing hamster heart. This distal organ repair mechanism activates production from the injected hamstring of many trophic factors, among which stromal-derived factor-1 (SDF1) prominently mobilized multi-lineage progenitor cells expressing CXCR4 and their recruitment to the heart. The mobilized bone marrow progenitor cells express the cardiac transcription factors myocyte enhancer factor 2c and GATA4 and several major trophic factors, most notably IGF1 and VEGF. SDF1 blockade abrogated myocardial recruitment of CXCR4(+) and c-kit(+) progenitor cells with an insignificant effect on the hematopoietic progenitor lineage. The knockdown of cardiac progenitor cells led to deprivation of myocardial trophic factors, resulting in compromised cardiomyogenesis and angiogenesis. However, the VEGF-injected hamstring continued to synthesize cardioprotective factors, contributing to moderate myocardial tissue viability and function even in the presence of SDF1 blockade. These findings thus uncover two distinct but synergistic cardiac therapeutic mechanisms activated by intramuscular VEGF. Whereas the SDF1/CXCR4 axis activates the progenitor cell cascade and its trophic support of cardiomyogenesis intramuscularly, VEGF amplifies the skeletal muscle paracrine cascade capable of directly promoting myocardial survival independent of SDF1. Given that recent clinical trials of cardiac repair based on the use of marrow-mobilizing agents have been disappointing, the proposed dual therapeutic modality warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963833      PMCID: PMC3233810          DOI: 10.1152/ajpheart.00343.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  61 in total

1.  CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities.

Authors:  Erik B Friedrich; Katrin Walenta; John Scharlau; Georg Nickenig; Nikos Werner
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

2.  Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells.

Authors:  Merced Leiker; Gen Suzuki; Vijay S Iyer; John M Canty; Techung Lee
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

3.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

Authors:  Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

4.  Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.

Authors:  Gen Suzuki; Vijay Iyer; Te-Chung Lee; John M Canty
Journal:  Circ Res       Date:  2011-09-01       Impact factor: 17.367

5.  Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart.

Authors:  Georgina M Ellison; Daniele Torella; Santo Dellegrottaglie; Claudia Perez-Martinez; Armando Perez de Prado; Carla Vicinanza; Saranya Purushothaman; Valentina Galuppo; Claudio Iaconetti; Cheryl D Waring; Andrew Smith; Michele Torella; Carlos Cuellas Ramon; Jose Manuel Gonzalo-Orden; Valter Agosti; Ciro Indolfi; Manuel Galiñanes; Felipe Fernandez-Vazquez; Bernardo Nadal-Ginard
Journal:  J Am Coll Cardiol       Date:  2011-06-30       Impact factor: 24.094

6.  Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.

Authors:  Victor Vacanti; Elton Kong; Gen Suzuki; Kazuki Sato; John M Canty; Techung Lee
Journal:  J Cell Physiol       Date:  2005-11       Impact factor: 6.384

7.  The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors.

Authors:  Abdelhak Belmadani; Phuong B Tran; Dongjun Ren; Stavroula Assimacopoulos; Elizabeth A Grove; Richard J Miller
Journal:  J Neurosci       Date:  2005-04-20       Impact factor: 6.167

8.  Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration.

Authors:  Domenico D'Amario; Mauricio C Cabral-Da-Silva; Hanqiao Zheng; Claudia Fiorini; Polina Goichberg; Elisabeth Steadman; João Ferreira-Martins; Fumihiro Sanada; Marco Piccoli; Donato Cappetta; David A D'Alessandro; Robert E Michler; Toru Hosoda; Luigi Anastasia; Marcello Rota; Annarosa Leri; Piero Anversa; Jan Kajstura
Journal:  Circ Res       Date:  2011-05-05       Impact factor: 17.367

9.  Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen.

Authors:  Arsalan Shabbir; David Zisa; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

Review 10.  Paracrine mechanisms in adult stem cell signaling and therapy.

Authors:  Massimiliano Gnecchi; Zhiping Zhang; Aiguo Ni; Victor J Dzau
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

View more
  14 in total

1.  Stem cell therapy independent of stemness.

Authors:  Techung Lee
Journal:  World J Stem Cells       Date:  2012-12-26       Impact factor: 5.326

Review 2.  Enhancing the efficacy of mesenchymal stem cell therapy.

Authors:  Michalis Mastri; Huey Lin; Techung Lee
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

3.  Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.

Authors:  Michalis Mastri; Zaeem Shah; Karin Hsieh; Xiaowen Wang; Bailey Wooldridge; Sean Martin; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

4.  Autologous serum supplement favours in vitro regenerative paracrine factors synthesis.

Authors:  Nazmul Haque; Noor Hayaty Abu Kasim; Noor Lide Abu Kassim; Mohammad Tariqur Rahman
Journal:  Cell Prolif       Date:  2017-07-06       Impact factor: 6.831

5.  Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

Authors:  Michalis Mastri; Zaeem Shah; Terence McLaughlin; Christopher J Greene; Leah Baum; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249

6.  sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling.

Authors:  Huey Lin; Mia Angeli; Kwang Jin Chung; Chukwuemeka Ejimadu; Angelica Rivera Rosa; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-07       Impact factor: 4.249

7.  Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts.

Authors:  Sean Martin; Huey Lin; Chukwuemeka Ejimadu; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2015-05-13       Impact factor: 4.249

Review 8.  Cardiac regeneration and diabetes.

Authors:  Lu Cai; Bradley B Keller
Journal:  Regen Med Res       Date:  2014-01-03

9.  Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts.

Authors:  Yan Yao; Ji Huang; Yongjian Geng; Haiyan Qian; Fan Wang; Xiaohui Liu; Meisheng Shang; Shaoping Nie; Nian Liu; Xin Du; Jianzeng Dong; Changsheng Ma
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

10.  Identification of a potent endothelium-derived angiogenic factor.

Authors:  Vera Jankowski; Markus Tölle; Thi Nguyet Anh Tran; Markus van der Giet; Mirjam Schuchardt; Kerstin Lehmann; Doreen Janke; Burkhard Flick; Alberto Ortiz; Alberto Arduan Ortiz; Maria D Sanchez-Niño; Niño Maria Dolores Sanchez; Martin Tepel; Walter Zidek; Joachim Jankowski
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.